Trial Profile
Open-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With Adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease; Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Innovaderm Research
- 28 Jun 2016 Status changed from active, no longer recruiting to completed.
- 22 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 22 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.